Status
Conditions
Treatments
About
EYEdeal Scanning Technology enables rapid measurement of corneal and scleral topography. By accurately measuring the ocular surface with this imaging technology, the current iterative fitting method required to fit PROSE (prosthetic replacement of the ocular surface ecosystem) devices could be replaced and/or strengthened with a more rapid, automated fitting sequence. This could considerably reduce the time needed per visit, the number of visits, and the number of devices needed to be manufactured to reach the endpoint. Additionally, the scanning technology may afford the opportunity to successfully fit some pathology that were previously treatment failures. The automated technology may as well reduce the intensive clinician training time needed to fit PROSE devices, therefore increasing the availability and access to patients.
The goal of this research is to evaluate the reliability and efficacy of this automated technology for fitting PROSE devices. Data from real-time measurement of the human eye ocular surface topography will be used to fabricate a prosthetic lens. The fit of the PROSE device will be evaluated, as well as the subjective comfort of the fit.
Full description
Inclusion and Exclusion Criteria
The participant will be eligible to participate if the following criteria apply:
The participant would NOT be eligible to participate if at least one of the following criteria is met:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Is currently participating in any other type of eye-related clinical or research study
Is pregnant or nursing as reported by the subject
Has a condition or is in a situation which, in the investigator's opinion, may put the subject at significant risk, may confound study outcomes, or may significantly interfere with the subject's participation in the study
Has had previous ocular surgery within the past 12 weeks
Intolerance to PROSE wear
Inability to maintain stable fixation and exposure for ocular surface imaging
Corneal touch by the posterior surface of the device in current PROSE device
Allergy to sodium fluorescein
Patient is an employee of BostonSight
Subject is currently incarcerated. -
Primary purpose
Allocation
Interventional model
Masking
11 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal